Rare diseases
Investigational molecules
Locations
Back to the Netherlands18 clinical trials in Hardenberg, The Netherlands. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
The NetherlandsPhase 3 Study of Etripamil Nasal Spray Compared with Placebo in Patients with Atrial Fibrillation and Rapid Ventricular Rate
The NetherlandsStudy on Levothyroxine and Liothyronine for Patients with Autoimmune Hypothyroidism and Persistent Tiredness
The NetherlandsStudy on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone
The NetherlandsStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
The NetherlandsPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
The NetherlandsEvaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction
The NetherlandsStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
The NetherlandsStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
The NetherlandsStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
The NetherlandsEvaluation of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Type 2 Diabetes Patients with High Cardiovascular Risk
The NetherlandsLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on cardiovascular disease management and prevention, including studies of new treatments for reducing major cardiac events and improving heart function.
Advanced research into both preserved and reduced ejection fraction heart conditions.
Comprehensive research on Type 2 Diabetes and thyroid conditions, evaluating innovative therapeutic approaches and treatment combinations.
Trials exploring personalized medicine approaches based on genetic variations.
Groundbreaking studies in chronic kidney disease treatment, investigating novel therapeutic combinations and their impact on disease progression.
Research spanning various stages of kidney disease, including transplant recipients.
Leading-edge trials in breast cancer and multiple myeloma, evaluating treatment strategies and therapeutic combinations.
Focus on improving progression-free survival and quality of life outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
